Individual responses vary based on the specific compounding formulation, injection site, and each patients metabolic baseline
Because terminology, peptide form, assay design, and reporting quality vary across the historical literature, study conclusions should remain tied to the exact sequence, disulfide configuration, counterion or salt form, formulation, species, route, exposure period, and endpoint used
Enhances energy expenditure at the cellular level, aiding in weight management
Lancet 397 , 971984 (2021)
Specific compatibility considerations include confirmation of absence of reducing agents for disulphide-containing peptides, BSA carrier supplementation for recombinant proteins, and acetic acid acidification for hydrophobic peptides requiring low pH solubilisation